Strategies to maintain remission in high risk CD19 lymphoid malignancies

Von Willebrand Factor and ADAMTS13

Use of autologous stem cell transplant in multiple myeloma

International workshop on chronic lymphocytic leukaemia 2013

Study shows pomalidomide prolongs survival in refractory myeloma patients

Use of Daratumumab, a CD38 monoclonal antibody, in advanced multiple myeloma

Targeting JAK-STAT pathway in malignant and non-malignant cells in myeloproliferative neoplasms

Addition of obinutuzumab or rituximab to chlorambucil for chronic lymphocytic leukaemia

Daratumumab, a CD38 monoclonal antibody study in advanced multiple myeloma

Monoclonal antibodies and targeting them against cancer cells in lymphoma

Neo-angiogenesis and pathological angiogenesis in targeted molecules

Role of microenvironment and stroma in cancer therapy